Methocarbamol

Common brands: Robaxin, Methocarbamol Tablets, Usp, 500 Mg, Methocarbamol Tablets, Usp, 750 Mg, Atmeksi, Methocarb 500-Ezs

Top reporter: Hikma Pharmaceuticals Usa Inc.

Muscle Relaxant [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Corticosteroid [EPC]Provitamin D2 Compound [EPC]
21,873
Total Reports
9,281
Serious Reports
1,708
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.81%)

Patient Demographics

Male
6,041
Female
14,413

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Methocarbamol.

# Reaction Reports % of Total
1 PAIN 1,678
6.3%
2 NAUSEA 1,621
6.1%
3 FATIGUE 1,591
6.0%
4 DRUG INEFFECTIVE 1,466
5.5%
5 HEADACHE 1,240
4.7%
6 DIARRHOEA 1,132
4.3%
7 FALL 1,071
4.0%
8 DYSPNOEA 1,022
3.8%
9 ARTHRALGIA 993
3.7%
10 DIZZINESS 937
3.5%
11 OFF LABEL USE 924
3.5%
12 BACK PAIN 906
3.4%
13 ANXIETY 899
3.4%
14 VOMITING 825
3.1%
15 DEPRESSION 812
3.1%
16 PAIN IN EXTREMITY 787
3.0%
17 CHRONIC KIDNEY DISEASE 766
2.9%
18 ASTHENIA 739
2.8%
19 PNEUMONIA 642
2.4%
20 MALAISE 641
2.4%
21 RASH 636
2.4%
22 MUSCLE SPASMS 631
2.4%
23 WEIGHT DECREASED 622
2.3%
24 PRODUCT DOSE OMISSION ISSUE 607
2.3%
25 INSOMNIA 606
2.3%
26 HYPERTENSION 595
2.2%
27 ACUTE KIDNEY INJURY 564
2.1%
28 PRURITUS 561
2.1%
29 DEATH 546
2.1%
30 RENAL FAILURE 530
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.